2. Hashimoto S, Kawado M, Murakami Y, et al. Incidence of infectious diseases estimated by the surveillance data in 2002-2004 in Japan. Nihon Koshu Eisei Zasshi. 2006; 53:794–799.
3. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999; 77:3–14.
4. Japanese Ministry of Health, Labour and Welfare. Monthly labour survey, e-stat annual survey, 2015. Tokyo: Japanese Ministry of Health, Labour and Welfare;2015.
6. Iwata S, Ishiwada N, Sakata H, Sakano T, Sato Y, Nakano T. Burden of illness of bacterial meningitis and bacteremia caused by Streptococcus pneumonia in children. Jpn J Pediatr. 2008; 61:2206–2220.
7. Japanese Ministry of Health, Labour and Welfare. Survey on the trend of medical care expenditures. Tokyo: Health Insurance Bureau of Medical Economics Division, Japanese Ministry of Health, Labour and Welfare;2010.
8. Hashimoto H, Fujioka M, Kinumaki H. Kinki Ambulatory Pediatrics Study Group. An office-based prospective study of deafness in mumps. Pediatr Infect Dis J. 2009; 28:173–175.
Article
9. Yamanaka N, Hotomi M, Sugata R. Cost-effectiveness of pneumococcal conjugate vaccine in Japan: estimation on acute otitis media in children. Jpn J Pediatr. 2008; 61:2221–2232.
10. Okubo S, Takahashi M, Kai I. How Japanese parents of deaf children arrive at decisions regarding pediatric cochlear implantation surgery: a qualitative study. Soc Sci Med. 2008; 66:2436–2447.
Article
11. Sugawara T, Ohkusa Y, Taya K, et al. Cost-effectiveness analysis of routine mumps immunization in Japan. Kansenshogaku Zasshi. 2007; 81:555–561.
Article
12. Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of mumps vaccine to the birth cohort in Japan. Vaccine. 2014; 32:4189–4197.
Article
13. Hosaka S, Komori K, Hoshina K, et al. Investigation about serious cases caused by mumps virus and varicella-zoster virus. J Jpn Pediatr Assoc. 2012; 33:182–186.
14. World Health Organization. Global Health Observatory data, world health statistics. Geneva: World Health Organization;2016.
15. Hashimoto S. Study for healthy life expectancy, healthy Japan 21st century, review of healthy life expectancy. Research Report of Scientific Research Grant from Japanese Ministry of Health, Labour and Welfare [Internet]. Tokyo: Japanese Ministry of Health, Labour and Welfare;2015. cited 2017 Feb 27. Available from:
http://www.pbhealth.med.tohoku.ac.jp/japan21/pdf/o-27-3.pdf.
16. Peltola H, Jokinen S, Paunio M, Hovi T, Davidkin I. Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. Lancet Infect Dis. 2008; 8:796–803.
Article
17. Japanese Ministry of Health, Labour and Welfare. Eligible population, the way of inoculation, and choice of vaccine strain for mumps vaccination [Internet]. Tokyo: Health Service Bureau, Division of Tuberculosis and Infectious Disease Control, Japanese Ministry of Health, Labour, and Welfare;2013. cited 2017 Feb 27. Available from:
http://www.mhlw.go.jp/stf/shingi/2r985200000371fc-att/2r985200000371w4.pdf.
18. Ihara T, Ochiai H. Mumps vaccine: progress toward the routine vaccination. Rinsyou Uirusu. 2014; 42:174–182.
19. Pickering LK, Baker CJ, Kimberlin DW, Long SS. Red Book. 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics;2012. p. 1–109.
21. Ihara T. Mumps vaccine effectiveness and adverse events: the need for 2-dose vaccination. Nihon Syounikai Kaihou. 2015; 49:55–60.
22. Baba K, Okuno Y, Tanaka-Taya K, Okabe N. Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan. Vaccine. 2011; 29:3089–3092.
Article
23. Muta H, Nagai T, Ito Y, Ihara T, Nakayama T. Effect of age on the incidence of aseptic meningitis following immunization with monovalent mumps vaccine. Vaccine. 2015; 33:6049–6053.
Article
24. Nishimura N. Mumps vaccine. Gendaiigaku. 2010; 58:175–180.
26. Wiedermann G, Ambrosch F. Costs and benefits of measles and mumps immunization in Austria. Bull World Health Organ. 1979; 57:625–629.
27. Nakagomi T, Nakagomi O. Cost-effectiveness of rotavirus vaccination using direct non-medical costs and opportunity costs estimated from the Internet survey data. Rinsyou Uirusu. 2013; 41:239–250.
28. Rubin SA, Plotkin SA. Mumps vaccine. In : Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia, PA: Saunders;2013. p. 419–446.